[go: up one dir, main page]

EP1009431A4 - Anticorps contre le recepteur de type 2 (tr2) du facteur de necrose des tumeurs humain - Google Patents

Anticorps contre le recepteur de type 2 (tr2) du facteur de necrose des tumeurs humain

Info

Publication number
EP1009431A4
EP1009431A4 EP98922245A EP98922245A EP1009431A4 EP 1009431 A4 EP1009431 A4 EP 1009431A4 EP 98922245 A EP98922245 A EP 98922245A EP 98922245 A EP98922245 A EP 98922245A EP 1009431 A4 EP1009431 A4 EP 1009431A4
Authority
EP
European Patent Office
Prior art keywords
antibodies
necrosis factor
tumor necrosis
factor receptor
human tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98922245A
Other languages
German (de)
English (en)
Other versions
EP1009431A1 (fr
Inventor
Jeremy A Harrop
Stephen D Holmes
Manjula P Reddy
Alemseged Truneh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of EP1009431A1 publication Critical patent/EP1009431A1/fr
Publication of EP1009431A4 publication Critical patent/EP1009431A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP98922245A 1997-05-12 1998-05-12 Anticorps contre le recepteur de type 2 (tr2) du facteur de necrose des tumeurs humain Withdrawn EP1009431A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4624997P 1997-05-12 1997-05-12
US46249P 1997-05-12
PCT/US1998/009744 WO1998051346A1 (fr) 1997-05-12 1998-05-12 Anticorps contre le recepteur de type 2 (tr2) du facteur de necrose des tumeurs humain

Publications (2)

Publication Number Publication Date
EP1009431A1 EP1009431A1 (fr) 2000-06-21
EP1009431A4 true EP1009431A4 (fr) 2000-09-27

Family

ID=21942431

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98922245A Withdrawn EP1009431A4 (fr) 1997-05-12 1998-05-12 Anticorps contre le recepteur de type 2 (tr2) du facteur de necrose des tumeurs humain

Country Status (4)

Country Link
EP (1) EP1009431A4 (fr)
JP (1) JP2001524985A (fr)
CA (1) CA2290067A1 (fr)
WO (1) WO1998051346A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427492B1 (en) 1995-06-05 2008-09-23 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor receptor-like2
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
US7118742B2 (en) 1997-07-07 2006-10-10 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US6140467A (en) * 1997-07-07 2000-10-31 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
CA2365405A1 (fr) * 1999-03-22 2000-09-28 Human Genome Sciences, Inc. Recepteur tr2 du facteur de necrose tumorale chez l'homme
WO2001079496A2 (fr) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand pour mediateur d'entree du virus herpes simplex et procedes de mise en oeuvre
EP1674575B1 (fr) * 2000-04-12 2010-10-06 La Jolla Institute For Allergy And Immunology Ligand du médiateur d'accès du virus de l'herpès simplex et procédés d'utilisation
AU2003228483A1 (en) * 2002-04-12 2003-10-27 Human Genome Sciences, Inc. Antibodies that specifically bind to tr2
US20100203047A1 (en) * 2007-10-05 2010-08-12 University Of Maryland, Baltimore Novel Compositions And Methods For Stimulating Erythropoiesis In A Mammal

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009137A1 (fr) * 1992-10-15 1994-04-28 Genentech, Inc. Anticorps contre le recepteur du facteur de necrose de tumeurs de type 2
WO1996034095A1 (fr) * 1995-04-27 1996-10-31 Human Genome Sciences, Inc. Recepteurs du facteur de necrose tumorale chez l'homme
WO1997004658A1 (fr) * 1995-07-28 1997-02-13 Northwestern University Entree du virus 1 de l'herpes dans des cellules, induite par un nouveau membre de la famille des recepteurs du facteur necrosant des tumeurs/facteur de croissance des nerfs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756096A (en) * 1991-07-25 1998-05-26 Idec Pharmaceuticals Corporation Recombinant antibodies for human therapy
WO1993023557A1 (fr) * 1992-05-08 1993-11-25 Receptagen Corporation Agents antirecepteurs diriges contre le recepteur de la vitamine b12/transcobalamine ii
AU7364696A (en) * 1996-09-18 1998-04-14 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like genes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009137A1 (fr) * 1992-10-15 1994-04-28 Genentech, Inc. Anticorps contre le recepteur du facteur de necrose de tumeurs de type 2
WO1996034095A1 (fr) * 1995-04-27 1996-10-31 Human Genome Sciences, Inc. Recepteurs du facteur de necrose tumorale chez l'homme
WO1997004658A1 (fr) * 1995-07-28 1997-02-13 Northwestern University Entree du virus 1 de l'herpes dans des cellules, induite par un nouveau membre de la famille des recepteurs du facteur necrosant des tumeurs/facteur de croissance des nerfs

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B. KWON ET AL.: "A newly-identified member of the tumor necrosis factor receptor superfamily.", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 99, no. 1 part 2, January 1997 (1997-01-01), St. Louis, MO, USA, pages S467, XP000929446 *
J. HARROP ET AL.: "Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.", THE JOURNAL OF IMMUNOLOGY, vol. 161, no. 4, 15 August 1998 (1998-08-15), Baltimore, MD, USA, pages 1786 - 1794, XP002143292 *
See also references of WO9851346A1 *

Also Published As

Publication number Publication date
EP1009431A1 (fr) 2000-06-21
CA2290067A1 (fr) 1998-11-19
JP2001524985A (ja) 2001-12-04
WO1998051346A1 (fr) 1998-11-19

Similar Documents

Publication Publication Date Title
EP0822984A4 (fr) Recepteurs du facteur de necrose tumorale chez l'homme
EP1007562A4 (fr) PROTEINES TANGO-63d ET TANGO-63e APPARENTEES AU RECEPTEUR DU FACTEUR DE NECROSE DES TUMEURS
EP1025228A4 (fr) Proteines tr11, tr11sv1 et tr11sv2 de type recepteur du facteur de necrose tumorale humain
EP0988371A4 (fr) Recepteur humain tr9 du facteur de necrose tumorale
DE69810130D1 (en) Rotationspumpe mit tauchrotor
EG23685A (en) Activated protein c formulations
EP0988062A4 (fr) Agents de contraste pour ultrasons a fixation selective
AU9013998A (en) Tumor necrosis factor receptor ztnfr-5
EP0993542A4 (fr) Appareil de cimentation antirotation
IL107288A0 (en) Antibodies against type 2 tumor necrosis factor receptor
AU7705198A (en) Human tumor necrosis factor receptor tr10
ZA952587B (en) Human tumor necrosis factor receptor
EP1055684A4 (fr) Derives de peptides d'antigene tumoral
AU7705098A (en) Human tumor necrosis factor receptor-like protein 8
DE19881579D2 (en) Kompressor mit überlastenkopplungseinrichtung
AU3766700A (en) Human tumor necrosis factor receptor-like 2
EP0961782A4 (fr) Recepteur tr2 du facteur de necrose tumorale chez l'homme
GB9700939D0 (en) Therapy
EP1009431A4 (fr) Anticorps contre le recepteur de type 2 (tr2) du facteur de necrose des tumeurs humain
EP0961832A4 (fr) Genes de type recepteurs du facteur de necrose tumorale humain
AU1541699A (en) Human tumor necrosis factor-r2-like proteins
EP1012262A4 (fr) Proteine humaine hflp
EP0574257A3 (fr) Récepteurs humains de glutamate se fixant à l'amino-hydroxy-méthyl-isoxazole-propionate.
AU9130598A (en) Tumor necrosis factor receptor ztnfr-6
EP1191940A4 (fr) Recepteur 5 du facteur de necrose tumorale

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991213

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20000809

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE DK FR GB IT LI NL

17Q First examination report despatched

Effective date: 20020425

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SMITHKLINE BEECHAM PLC

Owner name: SMITHKLINE BEECHAM CORPORATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040810